| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,014 | 5,034 | 6,142 | 7,022 | | Cost of Revenue | 570 | 507 | 645 | 673 | | | Gross Profit | 4,444 | 4,527 | 5,497 | 6,349 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (1,819) | 2,990 | 2,315 | 2,667 | | Non Recurring | 3,167 | (1,248) | (1,919) | 31,989 | | Others | 842 | 855 | 837 | (2,133) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 532 | 1,930 | 4,264 | (26,174) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,422) | 1,197 | 350 | (286) | | Earnings Before Interest And Taxes | (680) | 917 | 4,614 | (26,460) | | Interest Expense | 1,472 | 1,458 | 2,111 | 1,928 | | Income Before Tax | (2,152) | (541) | 2,503 | (28,388) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,152) | (541) | 2,503 | (28,388) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (430) | (541) | 2,503 | (28,388) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($430) | ($541) | $2,503 | ($28,388) |
|
0.02% Nasdaq 
0.16 (2.15%) 
Income Statement
